Status:
NOT_YET_RECRUITING
Role of Embolization of Thyroid Arteries as a Treatment for Different Thyroid Disorders
Lead Sponsor:
Assiut University
Conditions:
Graves Disease
Goiter, Nodular
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
To investigate the safety and efficacy of selective embolization of thyroid arteries (SETA) as adjunctive or definitive treatment in different thyroid disorders
Detailed Description
In graves disease Traditional forms of treatment of the thyroid diseases: pharmacotherapy, radioiodine therapy and surgery can not always be applied. Intolerance, side effects of antithyroid drugs, lo...
Eligibility Criteria
Inclusion
- A- diffuse and Nodular goiter:
- B-Toxic goiter:
- C-Thyroid cancer:
Exclusion
- A. Significant bleeding diathesis. B. Contraindication for contrast media (renal impairment or allergy). C. Severe atherosclerotic disease prevent arterial catheterization. D. Refusal of signing a consent
Key Trial Info
Start Date :
August 10 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 30 2026
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06537141
Start Date
August 10 2024
End Date
July 30 2026
Last Update
August 5 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.